A Randomized Clinical Trial of and Actual Use Study of Bococizumab (PF-04950615; RN316) and an Autoinjector (Pre-Filled Pen) in Patients with High Cholesterol (SPIRE-AI)
A 12 Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability and Actual Use of Bococizumab and an Autoinjector (Pre-Filled Pen) in Subjects with Primary Hyperlipidemia or Mixed Dyslipidemia
Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: Bococizumab (PF-04950615)
ClinicalTrials.gov Identifier (NCT): NCT02458287
Protocol ID: B1481046
PrintDownloadOpen Plain Language Summary Result: Click here